Evolent Health Newsroom

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39

Futu NewsOct 31 17:33

Evolent Health Is Maintained at Buy by Citigroup

Dow JonesOct 30 06:08

Evolent Health Analyst Ratings

BenzingaOct 30 05:58

Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $33

Futu NewsOct 30 04:31

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 24 20:31

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 16 20:31

TD Cowen Reaffirms Their Buy Rating on Evolent Health (EVH)

TipRanksOct 16 19:57

Evolent Health Analyst Ratings

BenzingaOct 8 22:15

RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $42

Futu NewsOct 8 19:31

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 3 19:31

TD Cowen Sticks to Their Buy Rating for Evolent Health (EVH)

TipRanksOct 3 19:18

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39

Futu NewsOct 3 17:33

J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $45

Futu NewsOct 3 08:32

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $33

Futu NewsSep 30 19:31

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $33

Futu NewsSep 27 19:31

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39

Futu NewsSep 27 17:32

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $39

Futu NewsSep 27 00:32

JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $43

Futu NewsSep 7 02:32

Evolent Health Buy Rating Affirmed With Increased Price Target Amid Growth Prospects and M&A Speculation

TipRanksSep 7 01:58

Evolent Health Is Maintained at Buy by Truist Securities

Dow JonesAug 27 22:27